Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
111 hedge funds and large institutions have $234M invested in Avid Bioservices, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 37 reducing their positions, and 16 closing their positions.
57% more call options, than puts
Call options by funds: $572K | Put options by funds: $365K
38% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 16
22% more capital invested
Capital invested by funds: $192M → $234M (+$41.9M)
6% more funds holding
Funds holding: 105 → 111 (+6)
30% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 37
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.8M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$4M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$3.74M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$3.46M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.78M |
| 2 |
Renaissance Technologies
New York
|
-$1.13M |
| 3 |
BlackRock
New York
|
-$842K |
| 4 |
ICM
ISZO Capital Management
New York
|
-$668K |
| 5 |
State Street
Boston,
Massachusetts
|
-$499K |
CDMO Hedge Fund Activity: Q3 2020 in Review
111 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2020, worth a combined $234M — up 22% from $192M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CDMO positions and 16 closed out — a net gain of 6 holders — while 26 added to existing stakes and 37 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.8M. The largest seller was Kennedy Capital Management, cutting an estimated $1.78M.
- 111 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2020, up from 105 in Q2 2020.
- Funds reported $234M of Avid Bioservices, Inc. Common Stock stock for Q3 2020, up 22% quarter-over-quarter.
- 22 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2020 and 16 closed out, a net change of +6 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2020 was Millennium Management, an estimated $4.8M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2020 was Kennedy Capital Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q3 2020.